SCHEMBL1765205

SCHEMBL1765205

CCCCc1ccccc1-c1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.49
PPARA Q07869 2/20 0.47
PTPN1 P18031 3/20 0.46
ABL1 P00519 2/20 0.44
ABCB1 P08183 2/20 0.44
BCR P11274 2/20 0.44
ESR1 P03372 3/20 0.43
ESR2 Q92731 2/20 0.43
LIPG Q9Y5X9 1/20 0.43
ADORA3 P0DMS8 3/20 0.43
ADRA2A P08913 2/20 0.43
TACR2 P21452 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
TP53 P04637 2/20 0.43
CYP3A4 P08684 2/20 0.43
ADORA2A P29274 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10441002 0.93 ESR1 (0.53) TYRPPARAESR1LIPGADORA3
SCHEMBL27434597 0.93 ESR1 (0.53) TYRPPARAESR1LIPGADORA3
SCHEMBL28138649 0.93 ESR1 (0.53) TYRPPARAESR1LIPGADORA3
SCHEMBL10441218 0.93 ESR1 (0.53) TYRPPARAESR1LIPGADORA3
SCHEMBL4383694 0.89 PPARA (0.49) PPARAPTPN1ABL1ABCB1BCR
SCHEMBL28804323 0.85 PPARA (0.49) PPARALIPGADORA3LTB4R2KMT2A
SCHEMBL15391163 0.85 PPARA (0.49) PPARALIPGADORA3LTB4R2KMT2A
SCHEMBL12610868 0.85 PPARA (0.49) PPARALIPGADORA3LTB4R2KMT2A
SCHEMBL367335 0.85 DPP4 (0.52) PPARALIPGLTB4R2KMT2ABID
SCHEMBL10767697 0.85 PTPN1 (0.46) TYRPTPN1ESR1ESR2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-1290641-A None JP disclosed
CN-118215651-A Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition 旭化成株式会社 2024-06-18 CN disclosed
EP-2028122-B9 Article comprising polypropylene composition BOREALIS TECH OY (FI) 2021-08-18 EP disclosed
EP-2028122-B2 Article comprising polypropylene composition BOREALIS TECH OY (FI) 2020-09-30 EP disclosed
CN-107463076-A Image forming apparatus 富士施乐株式会社 2017-12-12 CN disclosed
CN-102675780-B Dispersion liquid, coating fluid, film, formed body, Electrophtography photosensor, image processing system, handle box and preparation method FUJI XEROX CORP. (JP) 2016-03-23 CN disclosed
CN-102952027-B Compound, charge transport film, photoelectric conversion device, Electrophtography photosensor and manufacture method, handle box and image processing system FUJI XEROX CORP. (JP) 2016-02-24 CN disclosed
US-9139709-B2 Article BOREALIS TECHNOLOGY OY (FI) 2015-09-22 US disclosed
US-8652604-B2 Low migration polyolefin composition BOREALIS TECHNOLOGY OY (FI) 2014-02-18 US disclosed
US-8609892-B2 Glucagon receptor antagonists, preparation and therapeutic uses ELI LILLY AND COMPANY (US) 2013-12-17 US disclosed
EP-1911798-A1 Low migration polyolefin composition Borealis Technology Oy (FI) 2008-04-16 EP disclosed
CN-101107347-A Grease composition for hub unit bearing, and hub unit bearing for vehicles NSK LTD (JP) 2008-01-16 CN disclosed
US-20070249688-A1 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses ELI LILLY AND COMPANY (US) 2007-10-25 US disclosed
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed
US-5948923-A Phenolepoxy resins prepared from an aqueous-phase-free process INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 1999-09-07 US disclosed
US-5844062-A Process for preparing phenolepoxy resins in the absence of an aqueous phase INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 1998-12-01 US disclosed
JP-H01290641-A NOVEL PHENOLIC COMPOUND MITSUBISHI PAPER MILLS LTD 1989-11-22 JP disclosed
CN-1005632-B Preparation method of heat-resistant chloroprene copolymer 纳幕尔杜邦公司 1989-11-01 CN disclosed
CN-86106968-A HEAT-RESISTANT CHLOROPRENE COPOLYMER 1987-06-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249688-A1 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses GLP1R, GCGR, GIPR TYR 1281/4885PPARA 181/4885PTPN1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.